Biotech

All Articles

ArsenalBio elevates $325M, rotates far from former lead possession

.Collection Biosciences is actually moving on up. The cell therapy firm has actually added on $325 t...

Lilly- supported fat burning biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to deb...

Aelis' marijuana usage medicine fails period 2b, steering Indivior to review $100M possibility

.Aelis Farma's hopes of protecting a simple, positive choice on a $100 million possibility remittanc...

ProKidney standstills stage 3 trial certainly not needed for cell treatment authorization

.ProKidney has actually stopped among a pair of stage 3 tests for its cell treatment for kidney illn...

Vaxcyte surges on 'impressive' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what analysts named "impressive" phase 1/2 data for its own 31-valent pneumococcal...

Recursion's brain illness trial reveals little evidence of effectiveness

.Recursion has discovered via an early examination of its own tech-enabled strategy to drug explorat...

Acepodia, Pfizer click with each other for chemistry-based tissue treatment

.Contact it a scenario of really good chemical make up: Acepodia, a biotech based upon Nobel Prize-w...

Praxis epilepsy medicine reduces seizures in phase 2 litigation

.Practice Precision Medicines has racked up another midphase succeed in epilepsy this year, along wi...

Three officers resign as Dyne messages combined information for DMD prospect

.After escaping a professional hold several years back, Dyne Therapy has exposed brand-new stage 1/2...

Arrowhead fires off stage 3 information in rare metabolic ailment in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its give in front of a potential showdown with Ion...